A survey of prenatal first-trimester aneuploidy screening among Hong Kong specialist obstetricians

Hong Kong Medical Journal

Volumn 15, Issue 6, 2009, Pages 447-451

  Chan, Y M ^a   Sahota, Daljit S ^a   Chan, O K ^a   Leung, T Y ^a   Lau, T K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Down syndrome; Mass screening; Nuchal translucency measurement; Pregnancy trimester, first; Quality assurance, health care

Indexed keywords

ANEUPLOIDY; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; HEALTH PROGRAM; HEALTH SURVEY; HONG KONG; HUMAN; PREGNANT WOMAN; PRENATAL SCREENING; SHORT SURVEY;

ACCREDITATION; ADULT; ANEUPLOIDY; DOWN SYNDROME; FEMALE; HEALTH CARE SURVEYS; HONG KONG; HOSPITALS, PUBLIC; HUMANS; KARYOTYPING; MASS SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; OBSTETRICS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRIVATE SECTOR; QUALITY ASSURANCE, HEALTH CARE;

EID: 76749100762     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.
2. National Institute for Health and Clinical Excellence (NICE). NICE Clinical Guideline. Antenatal care: routine care for healthy pregnant woman. London: National Collaborating Centre for Women's and Children's Health; 2008: 62.
3. Leung TY, Chan LW, Law LW, et al. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med 2008;13:1-5.
4. Lau TK, Evans MI. Second-trimester sonographic soft markers: what can we learn from the experience of firsttrimester nuchal translucency screening? Ultrasound Obstet Gynecol 2008;32:123-5.
5. Wøjdemann KR, Larsen SO, Rode L, et al. First trimester Down's syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A. Scand J Clin Lab Invest 2006;66:101-11.
6. Schmidt P, Staboulidou I, Elsässer M, Vaske B, Hillemanns P, Scharf A. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening? Fetal Diagn Ther 2008;24:291-5.
7. Wah YM, Chan LW, Leung TY, Fung TY, Lau TK. How true is a 'true' midsagittal section? Ultrasound Obstet Gynecol 2008;32:855-9.
8. Monni G, Zoppi MA, Ibba RM, Floris M. Fetal nuchal translucency test for Down's syndrome. Lancet 1997;350:1631; author reply 1631-2.
9. Driscoll DA, Gross SJ; Professional Practice and Guidelines Committee. First trimester diagnosis and screening for fetal aneuploidy. Genet Med 2008;10:73-5.
10. Benn PA, Collins R. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome. Ann Clin Biochem 2001;38:28-36.
11. Spencer K. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Ann Clin Biochem 2005;42:30-40.